B-Cell Non-Hodgkin Lymphoma — Trials

B-Cell Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

6,181 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,757
Recruiting: 905
Ph III recruiting: 103
Growth YoY: +3.6%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (954)

clinicaltrialsPublishedShowing 1,651–1,700 of 2,052 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07028970	Long-term Follow-up Registry Study of Equecabtagene Autoleucel Injection	recruiting	—	1,500	Nanjing IASO Biotechnology Co., Ltd.INDUSTRY	1	Jun 19, 2025	clinicaltrials
NCT06550427	Early Assessment of Lymphoma Treatment Response Using Phased Variant Analysis With Next-Generation Sequencing	recruiting	—	200	National Taiwan University HospitalOTHER	1	Jun 17, 2025